AVPR1A and neoplasm: Furthermore, in vivo treatment with an AVPR1A antagonist (Relcovaptan) resulted effective in the control of orthotopic and subcutaneous xenograft tumors growth after mice castration, suggesting that the stimulation of this receptor promotes tumor growth in castration resistant PCa [75] (Fig. 4).